… Retinal Cell and Gene Therapy Innovation Summit For more information visit the conference … ProQR to present at the Retinal Cell and Gene Therapy Innovation Summit. …
… ProQR Announces R&D Day and Provides Update on Innovation Portfolio First Investor R&D Day on March 14, 2016 … amaurosis (LCA), today presents an update on the innovation pipeline and announces an R&D day for investors. …
… ProQR Receives € 4.7 million in Innovation Credit from Dutch Government for QR-110 for LCA10 … only by market approval of QR-110. Innovation credit (“Innovatiekrediet”) The Innovation Credit is awarded by the …
… ProQR to Present at the Retinal Cell and Gene Therapy Innovation Summit and the Association for Research in Vision … at the 7th Annual Retinal Cell and Gene Therapy Innovation Summit being held Friday, April 29, 2022 and the … U.S. Presentations at the Retinal Cell and Gene Therapy Innovation Summit Presentation title: AON treatment for …
… platform for the exchange and sharing of insights and innovations to drive the future of clinical development in … platform for the exchange and sharing of insights and innovations to drive the future of clinical development in …
ProQR will host a virtual Analyst and Investor Event on Wednesday, December 11, 2024 from 10:00 am until approximately 12:30 pm EST, including an Analyst Q&A session with members of the ProQR Management Team.